๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
NCT02650401Solid Tumors, CNS Tumors
Hoffmann-La Roche
Phase 1/2
69
Shanghai, Beijing
2016-05-03
Recruiting
Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies
NCT02961101Malignancies Multiple
Han weidong
Phase 1/2
250
Beijing
2016-05
Active, closed
Nomogram for Predicting In-stent Stenosis After Pipeline Embolization Device Treatment in Patients With Intracranial Aneurysm
NCT06715930Intracranial Aneurysm
Beijing Tiantan Hospital
Observational
1,500
Beijing
2016-04-01
Recruiting
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT02966483Rectal Neoplasms Malignant, Surgery
Sun Yat-sen University
Not applicable
1,114
Beijing, Chongqing, Guangzhou, Zhanjiang, Zunyi, Changsha, Hengyang, Changchun
2016-04
Recruiting
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
NCT04398992Acute Aortic Syndrome
Nanjing Medical University
Observational
10,000
Beijing, Chongqing, Guangzhou, Nanning, Xingyi, Harbin, Changzhou, Suqian
2016-01-01
Recruiting
A Registry Study of Biomarkers in Heart Valve Disease
NCT06223906Cardiovascular Diseases
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Observational
200,000
Beijing
2016-01-01
Recruiting
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
NCT07039552Hereditary Breast and Ovarian Cancer Syndrome, BRCA Mutations
Peking University Third Hospital
Observational
10,000
Beijing
2016-01-01
Recruiting
CCTA Improves Clinical Management of Stable Chest Pain
NCT04691037Coronary Computed Tomography Angiography, Stable Chest Pain, Optimal Medical Therapy, Invasive Coronary Angiography
Tianjin Chest Hospital
Observational
50,000
Beijing, Langfang, Tianjin
2016-01-01
Recruiting
A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation
NCT06513780Portal Vein Thrombosis
Ru-zhou Cai
Observational
700
Beijing
2016-01-01
Recruiting
Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
NCT07184814Takayasu Arteritis With Pulmonary Artery Involvement, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
China-Japan Friendship Hospital
Observational
150
Beijing
2016-01-01
Recruiting
Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD
NCT02918188Chronic Graft-versus-host Disease
Navy General Hospital, Beijing
Phase 2
21
Beijing
2016-01
Recruiting
A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
NCT03372980Takayasu's Arteritis
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Observational
1,000
Beijing
2016-01
Active, closed
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients
NCT02430103Breast Cancer
Peking University People's Hospital
Observational
349
Beijing
2015-12-25
Active, closed
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
NCT02637687Solid Tumors Harboring NTRK Fusion
Bayer
Phase 1/2
154
Beijing, Guangzhou, Tianjin
2015-12-16
Active, closed
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
NCT02584933ALK Positive Malignancies
Novartis Pharmaceuticals
Phase 4
233
Guangzhou, Changchun, Beijing
2015-12-11
Recruiting
Acupuncture or Metformin for Insulin Resistance in Women With PCOS
NCT02647827Polycystic Ovary Syndrome, Insulin Resistance, Hyperandrogenism
Karolinska Institutet
Phase 2
303
Beijing
2015-12
Active, closed
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318Prostate Cancer
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai
2015-11-27
Active, closed
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms
Hoffmann-La Roche
Phase 2
534
Harbin, Wuhan, Chengdu, Beijing, Guangzhou, Hangzhou, Shanghai, Shenzhen
2015-11-19
Active, closed
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
NCT02531516Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Ningbo
2015-11-19
Active, closed
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
NCT02542293Non Small Cell Lung Carcinoma NSCLC
AstraZeneca
Phase 3
953
Beijing, Changchun, Chongqing, Guangzhou, Hangzhou, Shanghai, รœrรผmqi, Wuhan
2015-11-03
Active, closed
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
NCT02516241Urothelial Cancer
AstraZeneca
Phase 3
1,126
Beijing, Changchun, Changsha, Chongqing, Hangzhou, Nanjing, Shanghai, Shenyang
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,400
Beijing
2015-11-02
Active, closed
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
NCT02486718Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 3
1,280
Beijing, Guangzhou, Hangzhou, Hefei, Shanghai, Shengyang, Shenyang, Suzhou
2015-10-31
Active, closed
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
NCT02511106Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca
Phase 3
682
Beijing, Changchun, Dalian, Guangzhou, Hangzhou, Kunming, Nanjing, Nanning
2015-10-21
Recruiting
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension ๏ผˆCTEPH๏ผ‰ Database in China
NCT05311072Chronic Thromboembolic Pulmonary Hypertension
China-Japan Friendship Hospital
Observational
1,500
Beijing
2015-10-01
Recruiting
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
NCT02535221Breast Cancer
Peking University
Phase 3
234
Beijing
2015-07-29
By invitation
AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer
NCT07042841Liver Cancer, Adult
Beijing Tsinghua Chang Gung Hospital
Observational
300
Beijing
2015-06-30
Recruiting
China Registry for Genetic / Metabolic Liver Diseases
NCT03131427Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital
Observational
20,000
Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Shanghai, Chengdu, Tianjin, รœrรผmqi
2015-06-13
Active, closed
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
NCT02375620Short Stature Children Born Small for Gestational Age (SGA)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
96
Beijing, Wuhan, Changsha, Wuxi, Nanchang, Changchun, Shanghai, Taiyuan
2015-04-23
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
Novartis Pharmaceuticals
Phase 4
279
Hangzhou, Beijing
2015-03-05
Active, closed
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
NCT02320435Solid Tumors
Hoffmann-La Roche
Phase 3
154
Beijing, Changchun, Chengdu, Hangzhou, Harbin, Nanjing, Shanghai, Shenyang
2015-02-02
Active, closed
Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure
NCT06023134Right Heart Failure, Pulmonary Hypertension
Jingyi Ren
Observational
800
Beijing
2015-01-01
Recruiting
De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
NCT06700369HER2-positive Breast Cancer
Shu Wang
Observational
519
Beijing
2015-01-01
Recruiting
Optimization Strategy of Carotid Artery Stenosis
NCT05629000Carotid Artery Stenosis
Peking Union Medical College Hospital
Observational
1,000
Beijing
2015-01-01
Recruiting
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
NCT06711055HER2-positive Breast Cancer
Shu Wang
Observational
285
Beijing
2015-01-01
Active, closed
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
NCT02152631Non Small Cell Lung Cancer
Eli Lilly and Company
Phase 3
453
Beijing, Changchun, Changzhou, Chengdu, Haikou, Hangzhou, Hefei, Nanning
2014-10-03
Recruiting
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
NCT02259556Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2014-10
Active, closed
RT for Cervical Adenocarcinoma/adenosquamous Carcinoma
NCT06741046Uterine Neoplasms, Genital Neoplasms, Female
Peking Union Medical College Hospital
Observational
400
Beijing
2014-06-01
Active, closed
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
NCT02032823Breast Cancer
AstraZeneca
Phase 3
1,837
Beijing, Changchun, Chengdu, Fuzhou, Hangzhou, Harbin, Jinan, Nanjing
2014-04-22
Recruiting
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
NCT03233087Aortic Aneurysm, Aortic Dissection
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Observational
1,500
Beijing
2014-03-01
Recruiting
Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
NCT05388682Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, PAH Targeted Medication
Chinese Pulmonary Vascular Disease Research Group
Observational
200
Beijing
2014-01-19
Recruiting
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
NCT07072858Myocardial Infarction (MI), ST Segment Elevation Myocardial Infarction (STEMI), Magnetic Resonance Imaging (MRI), Heart Ventricles
Chinese PLA General Hospital
Observational
1,000
Beijing
2014-01-01
By invitation
To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of Mycobacterium Abscessus Infection.
NCT07615309Mycobacterium Abscessus Infection, NTM Lung Infection Due to MAC
Beijing Chest Hospital
Observational
200
Beijing
2014-01-01
By invitation
Clinical Cohort Construction Program of Peking University Third Hospital
NCT07762144Post-Cardiac Arrest Syndrome
Peking University Third Hospital
Observational
500
Beijing
2014-01-01
Recruiting
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
NCT02918032Neutral Lipid Storage Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Beijing
2014-01
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
700
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shanxi, Suzhou
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
AstraZeneca
Phase 3
327
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin
2013-09-03
Recruiting
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
NCT03138941Systemic Lupus Erythematosus
Monash University
Observational
5,000
Beijing
2013-09-01
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin
2013-08-26
Recruiting
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT04074538Colorectal Cancer
Ding Ke-Feng
Observational
55,000
Hangzhou, Beijing, Chengdu, Guangzhou, Shanghai
2013-01-01
Recruiting
Beta Amyloid PET/CT in Various Aฮฒ-Related Disease
NCT06725706Amyloid, Beta-Amyloid, Neurodegenerative Diseases
Tianjin Medical University
Observational
500
Hefei, Beijing, Qingdao, Tianjin
2012-09-01
Recruiting
Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage
NCT04785976Aneurysmal Subarachnoid Hemorrhage
Beijing Tiantan Hospital
Observational
5,000
Beijing, Neijiang
2012-04-01
Active, closed
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)
NCT01688908Esophageal Squamous Cell Carcinoma, Dysplasia
Peking University
Not applicable
33,948
Beijing
2012-01-01
Recruiting
Establishing Prospective Mediastinal Tumor Database of PUMCH
NCT06421805Thymic Epithelial Tumor, Teratoma, Thymic Cyst, Retrosternal Goitre
Peking Union Medical College Hospital
Observational
2,000
Beijing
2012-01-01
Active, closed
Chinese Cohort Study of Chronic Kidney Disease
NCT03041987Renal Insufficiency, Chronic
Peking University First Hospital
Observational
5,000
Beijing
2012-01-01
Recruiting
Registry of Multicenter Brain-Heart Comorbidity in China
NCT05961748Ischemic Heart Disease, Cardiac Arrest, Atrial Fibrillation, Heart Failure
Beijing Tiantan Hospital
Observational
100,000
Beijing, Fuzhou, Xiamen, Shenzhen, Harbin, Zhengzhou, Shanghai, Shanxi
2012-01-01
Recruiting
A Prospective Cohort Study of IgG4RD in China
NCT01670695IgG4-related Disease
Peking Union Medical College Hospital
Observational
1,000
Beijing
2012-01
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Nanning, Chengdu, Beijing, Dalian, Guangzhou, Hangzhou, Harbin, Kunming
2012-01
Recruiting
Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
NCT04572568Brain Arteriovenous Malformation
Beijing Tiantan Hospital
Observational
2,000
Beijing
2011-08-01
Recruiting
Chinese Atrial Fibrillation Registry
NCT06987825Atrial Fibrillation (AF)
Beijing Anzhen Hospital
Observational
100,000
Beijing, Hangzhou
2011-08-01
Recruiting
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
NCT02696135Cardiomyopathy, Hypertrophic
China National Center for Cardiovascular Diseases
Observational
3,000
Beijing
2011-03-23
Recruiting
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
NCT06541106Dissecting Aneurysm of Cerebral Artery
Beijing Tiantan Hospital
Observational
2,000
Beijing
2011-01-01
By invitation
Chinese Population Health and Multimorbidity Study
NCT07026370Chronic Respiratory Diseases, Cardiovascular and Cerebrovascular Diseases, Malignant Tumors, Endocrine and Metabolic Diseases
China-Japan Friendship Hospital
Observational
50,991
Beijing
2011-01-01
Recruiting
Chinese PE Multimodality Imaging Artificial Intelligence Study
NCT06526468Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Disease
China-Japan Friendship Hospital
Observational
1,500
Beijing
2010-09-01
Recruiting
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
NCT02836158Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing
Phase 2/3
100
Beijing
2010-09
Recruiting
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
NCT02657785Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing
Phase 2/3
100
Beijing
2010-09
Recruiting
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Chinese Pulmonary Vascular Disease Research Group
Observational
4,000
Beijing
2010-09
Recruiting
Cardiac Magnetic Resonance for Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy
NCT07351838Non-ischemic Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2010-01-01
Recruiting
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
NCT07336394Danon Disease, Fabry Disease, Cardiac Amyloidosis, Noonan Syndrome
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2010-01-01
Recruiting
CMR-Based Prognostic Study in Patients With Cardiac Implantable Electronic Devices
NCT07336225Arrhythmias
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,500
Beijing
2010-01-01
Recruiting
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
NCT02851784Hepatocellular Carcinoma
Chinese PLA General Hospital
Phase 2/3
80
Beijing
2009-12
Recruiting
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
NCT06462742Overall Survival, Disease-free Survival
Chinese PLA General Hospital
Observational
1,000
Beijing
2009-01-01
Recruiting
CMR Prognostic Markers in Ischemic Heart Disease
NCT07351825Ischemic Heart Disease (IHD), Myocardial Infarction (MI)
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2009-01
Active, closed
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
NCT00781612Neoplasm Metastasis
Genentech, Inc.
Phase 2
378
Beijing, Changchun, Guangzhou, Hangzhou, Harbin, Nanjing, Shanghai
2008-10-16
Recruiting
Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging
NCT07474571Osteoarthitis, Osteoporosis
Peking University People's Hospital
Observational
2,000
Beijing
2005-11-01
Recruiting
Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk
NCT00289380Malnutrition, Nutritional Risk
Peking Union Medical College
Observational
2,000
Beijing, Chongqing, Guangzhou, Nanning, Shijiazhuang, Tianjin, Wuhan, Nanjing
2005-01
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Beijing, Guangzhou, Jinan, Shanghai
2004-09-15
Recruiting
Prospective Urban Rural Epidemiology Study
NCT03225586Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure
Population Health Research Institute
Observational
200,000
Beijing
2002-01-01
Recruiting
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
NCT04821778Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation, Targeted Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
2,000
Anyang, Changsha, Nanjing, Beijing
2002-01-01
Recruiting
Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT04821843Esophageal Cancer, Chemotherapy Effect, Chemoradiation, Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
2,000
Beijing
2002-01-01
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742Fabry Disease
Genzyme, a Sanofi Company
Observational
9,000
Beijing, Hangzhou, Jinan, Nanjing, Shanghai
2001-07-31
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
NCT02832245Venous Thromboembolism
Manuel Monreal
Observational
120,000
Beijing
2001-03
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Beijing, Guangzhou, Hangzhou, Nanjing, Shanghai
1991-04-01
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Beijing, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming
1983-01
Rows per page Showing 5401–5484 of 5484
Previous 53 54 55
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=55

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.